Characteristic of Play: Comparison Between Children With Development Coordination Disorder ( DCD) and Children With Typical Development
NCT ID: NCT01130038
Last Updated: 2011-08-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
64 participants
OBSERVATIONAL
2010-08-31
2011-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Developmental Coordination Disorder
NCT05154799
Development of Children With DCD Before the Age of Six
NCT03690843
Early Development and Diagnostic Trajectories in DCD
NCT05617586
Rhythmic Handwriting Deficits and General Rhythmic Abilities in Children
NCT06006767
Rhythmic Interlimb Coordination in Children with Developmental Coordination Disorder
NCT04891562
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Children with DCD and Typical Development
No interventions assigned to this group
Children with DCD
2 groups Children with DCD and Typical Development
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Study in regular education system
* The DCD diagnosis must be confirmed by a pediatrician
Exclusion Criteria
* Score below 3.83 in Children Activity Scale for Parents
* routinely take medication
* any physical limitations
* neurologic and/or muscle disease
* any significant hearing and/ or vision limitations
4 Years
6 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Meir Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clalit Medical Center
Gush Dan (Dan Area), , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
032/2010k
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.